about
Prevalence of monoclonal gammopathy of undetermined significance: a systematic reviewDrug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.Immunophenotypic studies of monoclonal gammopathy of undetermined significanceNovel therapies in multiple myeloma for newly diagnosed nontransplant candidatesMyelin protein zero is naturally processed in the B cells of monoclonal gammopathy of undetermined significance of immunoglobulin M isotype: aberrant triggering of a patient's T cellsMembranoproliferative glomerulonephritis secondary to monoclonal gammopathy.Robert Arthur Kyle, MD: a conversation with the editor.Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications.Multiple myeloma dell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation.Crosstalk between microRNA30a/b/c/d/e-5p and the canonical Wnt pathway: implications for multiple myeloma therapyCYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone diseaseThe evolving use of serum free light chain assays in haematology.CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathwayDetermining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.Characterization of monoclonal gammopathy of undetermined significance by calorimetric analysis of blood serum proteome.Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significance.The role of serum protein electrophoresis in the detection of multiple myeloma: an experience of a corporate hospital.Monoclonal gammopathy of undetermined significance associated with blue finger syndromeManagement of paraproteinaemia.Immunodeficiency and immunotherapy in multiple myeloma.Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma.Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.A Case of Undiagnosed HIV Infection in a 57-Year-Old Woman with Multiple Myeloma: Consequences on Chemotherapy Efficiency and Safety.Pathogenesis and progression of monoclonal gammopathy of undetermined significance.The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia.Familial myeloma.Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferationNEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma.Biological aspects of angiogenesis in multiple myeloma.Targeting the IGF-1R signaling and mechanisms for epigenetic gene silencing in human multiple myelomaA comparative review of aging and B cell function in mice and humansTiming of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes.Secondary immunodeficiency in lymphoproliferative malignancies.Transient Monoclonal Gammopathy Induced by Disseminated Staphylococcus aureus Infection.Monoclonal gammopathy of undetermined significance: significant beyond hematology.Prevalence of paraproteinaemia in older Australians.Computer-assisted detection of monoclonal components: results from the multicenter study for the evaluation of CASPER (Computer Assisted Serum Protein Electrophoresis Recognizer) algorithm.
P2860
P921
Q24597406-C6045485-C850-4897-83A8-5042E57A0A6BQ27692033-C864DB2C-5960-469E-B744-F1581DB9E637Q33387979-C72F8576-2DD1-451A-BB9C-4FE86D479D77Q33639796-482AE539-8016-4C89-B5E4-2A1E465D33FAQ33800466-A184A6FD-47E5-4C71-831B-D7FFC2793BA4Q33827448-0E516C44-DADB-4E9E-94B5-87576EA19245Q34145491-D36CD148-CBC4-441B-BAAC-0FCCC07BFA07Q34184698-CD905E19-6C0B-42F8-9276-BC3E64B4B7FBQ34221664-4BE92607-745B-4F01-822C-03B52431CB18Q34287900-1692FA3D-AEA1-44E3-BEC8-D3442D18DA25Q34292995-9801186D-CEED-427B-B0F7-33FCD70BF7D1Q34758218-A2B402CD-AB5B-4C4D-9301-64EFC745CE0AQ34898664-54111AB7-80CD-4099-817A-5A534BB97460Q35132283-45B3FD31-A4E8-4A1D-8BF8-3457452E4695Q35202780-A3309BF2-CF76-4A33-948F-9E2FC17D5A76Q36022586-83A5F149-4551-4638-8724-BAF4CDB26E3DQ36481350-99E5CEA8-FB1E-4687-A161-6E40F6F99736Q36703424-1F9E1FD8-2F83-47B0-AC83-6FE8C33E793DQ36778432-3BEAAE8A-52CD-45AC-97D2-2A9CB53B8E82Q36904977-B2850788-5B7D-4517-8D4F-4F88841F0845Q36938798-E5B22DF7-6C38-4FFF-9843-24E00F171E37Q37004853-A7C3A062-48B9-4E74-8AFD-35BBFEA39C08Q37004877-58221A1D-853F-46C8-9959-B12A37B73E2AQ37147418-9BC53022-7824-45C5-AE77-0EBFD01652B0Q37230910-D2E75256-2A5B-4DAA-89ED-391A0E7E5953Q37307571-6C8231E8-08C0-4AF7-89F7-305B028B788CQ37417096-FF1B62A0-82C3-4F47-BB70-DD5D6954CB7FQ37561552-509465F9-F9D2-41F4-8912-648F77CD3047Q37638021-AEB8CB56-04F7-4F24-B670-0202CC38A79EQ37801382-E595AEB9-C41A-41F1-9B87-9517F1A24335Q37956524-D5252E12-E2D1-4A78-A15A-1BDA2272D1B5Q37986142-470014E3-75F6-49B4-A89B-D395EA48696FQ38128010-ED3BC5C1-F863-4D4C-8400-E211F72675FEQ38377097-036D2083-5BB1-4C9E-AE5D-6C4B99820364Q38839768-4897B25B-D123-4700-AD0F-A47C71ACA397Q38893343-848E47DC-F1E5-4715-B8D2-A98DC28EAFFBQ42412796-CD0E57C3-CEE4-460B-9B85-9BE789FB6EDFQ42540873-5715C8DC-36C8-44E1-98F0-68F4C946A4C1Q43702726-D8D05CFB-4534-49B2-9C62-0B1ACCEB70A7Q46491006-14BDABBA-A694-4B21-B91E-0048F48B3A1D
P2860
description
article
@en
im September 2006 veröffentlichter wissenschaftlicher Artikel
@de
наукова стаття, опублікована у вересні 2006
@uk
name
Monoclonal gammopathy of undetermined significance
@en
type
label
Monoclonal gammopathy of undetermined significance
@en
prefLabel
Monoclonal gammopathy of undetermined significance
@en
P2860
P1476
Monoclonal gammopathy of undetermined significance
@en
P2093
Robert A Kyle
P2860
P304
P356
10.1111/J.1365-2141.2006.06235.X
P407
P577
2006-09-01T00:00:00Z